Public Health Agency of Canada

The award-winning Health Infobase, a sub-domain of Canada.ca, provides Canadian health information on a wide variety of topics including chronic and infectious diseases, injuries, mental health, health behaviours, health inequalities, consumer products, pesticides, wastewater, wildfires, and many...

This document also discusses an approach to managing COVID-19 vaccines that are administered in a manner that differs from the recommendations of the manufacturer as authorized by Health Canada and/or the recommendations for use by National Advisory Committee on Immunization (NACI). These are...

This evergreen document will be updated as COVID-19 vaccines are authorized and become available for use in Canada, and as evidence on these vaccines and COVID-19 evolves. This table summarizes the latest changes to this current version. Please refer to the Table of updates for a full list of...

Drugs and vaccines that have been authorized by Health Canada for use in relation to the COVID-19 pandemic are listed in this document.

The health and safety of Canadians is our priority. Along with measures reported in the Government of Canada's response to COVID-19, Health Canada introduced innovative and agile regulatory measures to make health products available to Canadians and health care workers. The COVID-19 pandemic...

Drugs included on this list are called "designated drugs" and are eligible for the exceptional importation and sale provisions provided for in Interim Order No. 2. Health Canada maintains and updates the list as required. It’s the same list that was incorporated by reference in the previous IO...

How to care at home for someone who has or may have been exposed to COVID-19.

This is a link to multiple publications of diseases and conditions in Canada.

3,673 isolates causing invasive pneumococcal disease (IPD) were characterized in 2019. Incidence rate of IPD for 2019 for children under <1 year of age is 13.2 cases per 100,000 population and for seniors ≥60 years to 21.2 cases per 100,000 population. The overall crude incidence rate has...

Information on the different types and uses of masks and respirators approved for use in Canada, and their importance during the COVID-19 pandemic to help slow the spread of coronavirus and protect health care providers.

The Public Health Agency of Canada (PHAC) uses the Canadian Chronic Disease Surveillance System (CCDSS) to conduct national surveillance of 20 chronic conditions, including diagnosed dementia ("all types of dementia" when not specifically mentioned) and diagnosed ischemic heart disease (IHD)....

Zoonotic diseases are infectious diseases caused by bacteria, viruses and parasites that spread between animals and humans. Lyme disease is a multisystemic infection which can lead to health issues such as erythema migrans rash, cardiac, neurologic or arthritic manifestations. It is caused by the...

The Infectious Disease and Climate Change Fund (IDCCF) addresses the impact of climate change on human health in Canada by: increasing capacity, enabling Canadians and communities and improving adaptability and resiliency.

Individual surveillance systems have various public health goals and policy objectives. In recent years, the scope of, and our reliance on, surveillance systems have grown significantly in all parts of the world because of globalization and threats of multi-drug resistant bacteria, bioterrorism...

The national incidence of foodborne pathogens is actively collected and reported by the National Enteric Surveillance Program (NESP). The NESP has been in operation since April 1997 and is designed to provide timely analysis and reporting of laboratory confirmed enteric disease cases in Canada.

The Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) monitors trends in antimicrobial use and antimicrobial resistance in selected bacterial organisms from human, animal and food sources across Canada. The program is based on several representative and...

This 2020 Canadian Antimicrobial Resistance Surveillance System (CARSS) Report provides a detailed assessment of antimicrobial resistance (AMR) in Canada. This report also provides recent information on the amount of antimicrobials used in humans and animals, as antimicrobial use (AMU) is one of...

This guidance supports high quality investigations that will contribute to public health’s collective understanding of COVID-19 transmission in all types of school settings and the utility of mitigation measures implemented. A systematic approach to outbreak response, including an investigation...

This document outlines the recommended goals, objectives, and activities for COVID-19 surveillance in Canada. These guidelines are based on current available scientific evidence and expert opinion and are subject to change as new information becomes available. They should be read in conjunction...

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases